Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada
Ocugen has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in Canada
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Researchers at ILS Bhubaneshwar develop animal models to study coronavirus
Animal models that closely resemble the pathogenesis of SARS-CoV-2-induced disease in humans are essential for research on disease…
CSIR and Laxai Life Sciences begin phase II trial of niclosamide drug to treat COVID-19
Niclosamide has been extensively used in the past for treating tapeworm infection in adults as well as children
Malta-based company to provide up to 60 million doses of Sputnik V vaccine to Haryana
The firm has given a timeline of 30 days to supply the first batch of five lakh doses, followed by 10 lakh doses every 20 days…
Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply
According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially
Understanding molecular actions may be key in treating severe COVID-19 cases: Study
A recent study at the Bar Ilan University has found that RNA molecules play a significant regulatory function in immune response…
SII gets approval from DCGI to produce Sputnik V vaccine in India
The firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology for developing Sputnik V at its…
Zydus Cadila gets CDSCO nod for clinical trials of antibodies cocktail to treat COVID-19: Sources
These antibodies are made by cloning unique white blood cells
US keen to work with Indian investigators in COVID-19 clinical trials: Dr Fauci
The partnerships between the NIH and India's DBT as well as the ICMR have helped produce important scientific and public health…
Countries, health partners deliberate on boosting response to COVID-19 in WHO South-East Asia Region
For five consecutive weeks, the Region reported rapid surge of COVID-19, registering over two million new cases
Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada
Biological E to produce Providence Therapeutics’ mRNA COVID-19 vaccine in India
It targets one billion dose production capacity in 2022
Moderna, Thermo Fisher sign agreement for fill/finish manufacturing of COVID-19 vaccine
Thermo Fisher’s commercial manufacturing site in Greenville, North Carolina will be used for aseptic fill/finish, labeling and…
Cipla seeks clarity, guidance from Govt for import of COVID-19 vaccine
The company is seeking fast-track approvals to expeditiously bring Moderna's single-dose COVID-19 booster vaccine into India
Sinovac COVID-19 vaccine gets WHO validation for emergency use
WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement
Scientists identify drug that prevents multiple coronavirus variants
Findings suggest that the drug diABZI activates the body's innate immune response, the first line of defence against invading…
Will be able to supply 9-10 crore doses of Covishield in June: SII
In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven…
IIT Hyderabad is ready for tech transfer of oral drug to treat ‘black fungus’
A 60-mg tablet, which can be priced at about Rs 200, is patient friendly as its slow and sustained release in the body reduces…
IIL to produce drug substance for Covaxin from June
Plans to dispatch the first batch to Bharat Biotech by July
120 days to make, test and release each Covaxin batch: Bharat Biotech
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP. There is a four-month lag…